Blood test for muscle loss in people on dialysis
Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether a simple blood test can help measure muscle loss in people on dialysis. If you join, researchers will check your blood levels and see how they relate to your muscle strength and function, which might help improve care for people with kidney failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have kidney failure and be on regular hemodialysis for more than 3 months.
- You should be feeling generally well—no hospital stays or infections in the past month.
- You must be willing to give your informed consent to join the study.
- You cannot have active cancer, advanced liver disease, major limb amputation, severe muscle/nerve disease, active autoimmune conditions, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
This study tests if gentle exercise during your dialysis sessions can help maintain muscle strength and improve sleep. If you are on chronic hemodialysis, at least 40 years old, and able to do simple exercises safely, you may be eligible.
This trial is for adults with chronic kidney disease and low muscle strength (sarcopenia). It aims to find ways to improve outcomes, especially if you have a higher risk of complications.
This study looks at proteins in the blood to understand muscle loss (sarcopenia) in people with chronic lung disease. It aims to find better ways to detect and manage this condition.
This trial tests if a supervised exercise program can help people on dialysis who have muscle wasting (uremic sarcopenia). It aims to improve muscle strength, physical function, and quality of life.
This trial tests whether a drug called roxadustat (taken as a pill) can help people on dialysis who also have sarcopenia (loss of muscle strength and mass). It aims to see if the drug improves muscle health and anemia.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.